Compliance to Long Term Imatinib Therapy in Newly Diagnosed Patients With Chronic Myeloid Leukaemia.
Phase of Trial: Phase IV
Latest Information Update: 12 Jun 2015
At a glance
- Drugs Imatinib (Primary)
- Indications Chronic myeloid leukaemia
- Focus Adverse reactions; Therapeutic Use
- 28 Oct 2009 Actual patient number (88) added as reported by ClinicalTrials.gov.
- 28 Oct 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 29 Mar 2008 New trial record.